logo

For the Inventor, By the Inventor

Marburg, Germany

Cenek Kolar

This inventor holds 23 USPTO granted patents, plus 3 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Behringwerke Aktiengesellschaft, Hoechst Aktiengesellschaft, Aventis Pharma Deutschland, Gmbh. Active years: 1984-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cenek Kolar. Retrieved from https://idiyas.com/inventor/cenek-kolar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 95.7

 

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 215(Granted Patents)


Location History:

  • Marburg an der Lahn, DE (1984)
  • Marburg, DE (1987 - 2007)

Company Filing History:

goldMedal15 out of 340 
 
Behringwerke Aktiengesellschaft
 patents
silverMedal5 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents
bronzeMedal2 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
4. 1 out of 1 
 
Laboratoires Hoechst
 patent
5. 1 out of 2 
 
Laboratories Hoechst S.a.
 patents
6. 1 out of 2 
 
Sanofi-Aventis Pharma Deutschland Gmbh
 patents
where one patent can have more than one assignee

Years Active: 1984-2007

Loading Chart...
Loading Chart...
Areas of Expertise:
Glycosylated Prodrugs
Anthracycline Derivatives
Cis-Platinum Complexes
Functionalized Enzyme Conjugates
Glycopeptide Derivatives
Gonadoliberin Antagonists
Beta-D-Galactose Derivatives
Amidinophenylalanine Derivatives
23 patents (USPTO):Explore Patents
1. 7241595 - Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates (2007-07-10),
2. 6610299 - Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates (2003-08-26),
3. 6475486 - Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates (2002-11-05),
4. 6146658 - Prodrugs, their preparation and use as pharmaceuticals (2000-11-14),
5. 5955100 - Prodrugs their preparation and use as pharmaceuticals (1999-09-21),
6. 5627283 - Amidinophenylalanine derivatives, a process for the preparation thereof, (1997-05-06),
7. 5561119 - Glycosylated prodrugs, their method of preparation and their uses (1996-10-01),
8. 5556941 - Glycopeptide derivatives, a process for their preparation and (1996-09-17),
9. 5457114 - Amidinophenylalanine derivatives, a process for the preparation thereof, (1995-10-10),
10. 5434138 - Gonadoliberin antagonists (1995-07-18),
11. 5260425 - Anthracycline derivatives having cytostatic activity (1993-11-09),
12. 5091521 - Cis-platinum complexes, a process for the preparation thereof, and (1992-02-25),
13. 5091367 - Analogs of gonadoliberin with improved solubility, methods for their (1992-02-25),
14. 5071836 - Competitive gonadoliberin antagonists (1991-12-10),
15. 5049549 - Rhodomycins with a modified carbohydrate unit (1991-09-17),

Title: The Inventor Profile of Cenek Kolar

Introduction: Cenek Kolar is a renowned inventor based in Marburg, Germany, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Cenek Kolar holds several patents in the areas of renewable energy technologies, medical devices, and advanced materials, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Cenek Kolar has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on industries worldwide.

Collaborations: Throughout his career, Cenek Kolar has collaborated with top scientists, engineers, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Cenek Kolar's passion for pushing the boundaries of technology and his relentless pursuit of excellence make him a standout figure in the world of inventions and innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…